Clinical Trial Update: A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This document outlines a Phase I/II clinical trial of ALETA-001 for various B-cell lymphomas, with recruitment ongoing and sponsored by Cancer Research UK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• ALETA-001

Snippet

Sponsor: Cancer Research UK | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse | Phase 1, Phase 2 | Status: RECRUITING